1. Home
  2. BEAM vs VVX Comparison

BEAM vs VVX Comparison

Compare BEAM & VVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • VVX
  • Stock Information
  • Founded
  • BEAM 2017
  • VVX 2014
  • Country
  • BEAM United States
  • VVX United States
  • Employees
  • BEAM N/A
  • VVX N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • VVX Diversified Commercial Services
  • Sector
  • BEAM Health Care
  • VVX Consumer Discretionary
  • Exchange
  • BEAM Nasdaq
  • VVX Nasdaq
  • Market Cap
  • BEAM 1.9B
  • VVX 2.0B
  • IPO Year
  • BEAM 2020
  • VVX 2014
  • Fundamental
  • Price
  • BEAM $26.62
  • VVX $68.81
  • Analyst Decision
  • BEAM Buy
  • VVX Buy
  • Analyst Count
  • BEAM 11
  • VVX 5
  • Target Price
  • BEAM $45.90
  • VVX $70.60
  • AVG Volume (30 Days)
  • BEAM 1.2M
  • VVX 126.3K
  • Earning Date
  • BEAM 11-05-2024
  • VVX 11-04-2024
  • Dividend Yield
  • BEAM N/A
  • VVX N/A
  • EPS Growth
  • BEAM N/A
  • VVX N/A
  • EPS
  • BEAM N/A
  • VVX 0.28
  • Revenue
  • BEAM $349,643,000.00
  • VVX $4,204,710,000.00
  • Revenue This Year
  • BEAM N/A
  • VVX $8.30
  • Revenue Next Year
  • BEAM $9.04
  • VVX $4.29
  • P/E Ratio
  • BEAM N/A
  • VVX $243.17
  • Revenue Growth
  • BEAM 328.73
  • VVX 7.79
  • 52 Week Low
  • BEAM $18.85
  • VVX $37.04
  • 52 Week High
  • BEAM $49.50
  • VVX $69.27
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 63.41
  • VVX 77.38
  • Support Level
  • BEAM $21.46
  • VVX $58.90
  • Resistance Level
  • BEAM $24.95
  • VVX $63.01
  • Average True Range (ATR)
  • BEAM 1.26
  • VVX 2.06
  • MACD
  • BEAM 0.36
  • VVX -0.00
  • Stochastic Oscillator
  • BEAM 88.97
  • VVX 95.56

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About VVX V2X Inc.

V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.

Share on Social Networks: